28.95
price down icon0.62%   -0.18
after-market After Hours: 28.96 0.01 +0.03%
loading

Genmab Adr Stock (GMAB) Forecast

The Genmab Adr (GMAB) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $49.25, representing a +70.11% increase from the current price of $28.95. The highest analyst price target is $51.20, and the lowest is $47.30.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month GMAB Price Target
Average 52.76 (+82.25% Upside)
loading

Is Genmab Adr (GMAB) A Buy Now?

Oscillators
Name Value Action
RSI(14) 39.42 Neutral
STOCH(9,6) 6.8258 Buy
STOCHRSI(14) 2.7947 Buy
MACD(12,26) -0.0168 Sell
ADX(14) 33.23 Sell
William %R -94.00 Buy
CCI(14) -85.76 Neutral
Buy: 3 Sell: 2 Neutral: 2
Summary: Buy
Moving Averages
Period Simple Exponential
MA10
30.34
Sell
30.06
Sell
MA20
31.48
Sell
30.40
Sell
MA50
29.02
Sell
28.92
Buy
MA100
25.46
Buy
26.65
Buy
MA200
23.00
Buy
24.96
Buy
Buy: 5 Sell: 5 Neutral: 0
Summary: Neutral
According to our latest analysis, GMAB could be considered a Potential Buy, with 17 technical analysis indicators signaling 8 Buy signals, 7 signaling Sell signals and 2 Neutral signals. This might be a good time to open fresh positions on GMAB, as trading bullish markets is always a lot easier
  1. RSI (Relative Strength Index): The RSI(14) value of 39.42 indicates that GMAB is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
  2. STOCH (Stochastic Oscillator): The STOCH value of 6.8258 indicates that GMAB is oversold. This indicates that GMAB price is at or near the lowest level over a specified lookback period.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 2.7947 indicates that GMAB is oversold. This suggests that GMAB price is at or near the lowest level relative to its recent price history.
  4. ADX (Average Directional Index): The ADX value of The ADX value of 33.23 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
  5. CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -85.76 indicates that GMAB is still oversold but not to an extreme extent.

Long-term GMAB price forecast for 2025, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Genmab Adr financial reports and earnings history, Genmab Adr (GMAB) stock could reach $43.21 by 2030, $84.80 by 2040 and $120.26 by 2050. See the projected annual prices until 2050 of the Genmab Adr stock below:

  • Genmab Adr (GMAB) is expected to reach an average price of $63.75 in 2035, with a high prediction of $65.66 and a low estimate of $61.16. This indicates an $120.20% rise from the last recorded price of $28.95.
  • Genmab Adr (GMAB) stock is projected to chart a bullish course in 2040, with an average price target of $77.53, representing an $167.80% surge from its current level. The forecast ranges from a conservative $77.04 to a sky-high $84.80.
  • Our analysts predict Genmab Adr (GMAB) to jump 252.29% by 2045, soaring from $101.96 to an average price of $101.99, potentially reaching $105.57. While $101.96 is the low estimate, the potential upside is significant.
  • Genmab Adr (GMAB) stock is expected to climb by 2050, reaching an average of $117.11, a $304.51% jump from its current level. However, a wide range of estimates exists, with high and low targets of $120.26 and $115.90, respectively, highlighting the market's uncertainty.

Genmab Adr Stock (GMAB) Year by Year Forecast

Genmab Adr Stock (GMAB) Price Forecast for 2025

Genmab Adr Stock (GMAB) is expected to reach an average price of $41.00 in 2025, with a high prediction of $54.15 and a low estimate of $27.86. This indicates an +41.63% rise from the last recorded price of $28.95.
Month Average Low High Change from today's price
November, 2025 $51.16 $47.30 $51.20 +76.71%
December, 2025 $53.32 $50.47 $54.15 +84.18%

Genmab Adr Stock (GMAB) Price Forecast for 2026

The predicted value for Genmab Adr (GMAB) in 2026 is set at an average of $52.76. Estimates vary from a peak of $62.57 to a trough of $42.95, indicating an +82.25% surge from the present price of $28.95.
Month Average Low High Change from today's price
January, 2026 $52.42 $52.35 $57.52 +81.07%
February, 2026 $46.70 $46.16 $54.76 +61.31%
March, 2026 $45.93 $42.95 $48.09 +58.65%
April, 2026 $49.84 $44.46 $50.29 +72.16%
May, 2026 $52.37 $48.53 $52.60 +80.90%
June, 2026 $56.13 $52.53 $58.13 +93.89%
July, 2026 $56.54 $53.90 $57.77 +95.31%
August, 2026 $59.98 $56.11 $61.03 +107.20%
September, 2026 $57.51 $57.47 $62.57 +98.64%
October, 2026 $56.80 $55.54 $58.61 +96.18%
November, 2026 $58.34 $55.64 $60.56 +101.54%
December, 2026 $52.34 $51.62 $61.01 +80.78%

Genmab Adr Stock (GMAB) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Genmab Adr (GMAB) is $47.47, with a high forecast of $54.19 and a low forecast of $40.75. This indicates an +63.97% increase from the last price of $28.95.
Month Average Low High Change from today's price
January, 2027 $53.60 $49.69 $54.19 +85.14%
February, 2027 $47.50 $47.35 $54.18 +64.06%
March, 2027 $46.31 $45.62 $49.47 +59.96%
April, 2027 $45.91 $44.21 $48.84 +58.58%
May, 2027 $50.93 $46.55 $51.95 +75.92%
June, 2027 $45.21 $45.06 $53.01 +56.17%
July, 2027 $44.74 $41.84 $45.60 +54.54%
August, 2027 $46.89 $40.75 $46.92 +61.97%
September, 2027 $50.37 $45.63 $50.99 +74.00%
October, 2027 $50.67 $49.12 $52.93 +75.03%
November, 2027 $52.31 $49.15 $52.55 +80.70%
December, 2027 $51.48 $46.34 $52.53 +77.84%

Genmab Adr Stock (GMAB) Price Forecast for 2028

In 2028, Genmab Adr (GMAB) is projected to reach an average price of $56.40, with a high projection of $62.69 and a low estimate of $50.12. This indicates an +94.82% rise from the last price of $28.95.
Month Average Low High Change from today's price
January, 2028 $55.02 $50.12 $55.02 +90.07%
February, 2028 $61.69 $54.20 $61.73 +113.10%
March, 2028 $57.66 $57.07 $62.69 +99.16%
April, 2028 $54.24 $53.81 $58.98 +87.34%
May, 2028 $52.91 $52.36 $55.57 +82.76%
June, 2028 $51.42 $50.20 $53.83 +77.61%
July, 2028 $57.24 $51.39 $57.30 +97.71%
August, 2028 $57.41 $55.17 $58.67 +98.31%
September, 2028 $54.41 $54.38 $58.20 +87.94%
October, 2028 $53.63 $52.74 $55.41 +85.25%
November, 2028 $53.47 $53.38 $58.74 +84.70%
December, 2028 $54.44 $51.85 $55.68 +88.05%

Genmab Adr Stock (GMAB) Price Forecast for 2029

The 2029 price forecast for Genmab Adr Stock (GMAB) is $47.09 on average, with a high prediction of $55.02 and a low estimate of $39.16. This represents an +62.66% increase from the previous price of $28.95.
Month Average Low High Change from today's price
January, 2029 $51.53 $51.43 $55.02 +78.01%
February, 2029 $44.77 $44.38 $52.19 +54.66%
March, 2029 $49.24 $44.14 $49.33 +70.10%
April, 2029 $48.81 $46.69 $49.35 +68.61%
May, 2029 $48.25 $46.39 $49.52 +66.68%
June, 2029 $44.53 $44.00 $46.67 +53.83%
July, 2029 $44.59 $43.10 $46.28 +54.04%
August, 2029 $46.85 $45.26 $48.77 +61.82%
September, 2029 $45.18 $44.46 $47.46 +56.05%
October, 2029 $39.82 $39.16 $46.07 +37.55%
November, 2029 $41.81 $39.53 $42.68 +44.42%
December, 2029 $42.37 $41.18 $43.19 +46.35%

Genmab Adr Stock (GMAB) Price Forecast for 2030

Genmab Adr Stock (GMAB) is expected to reach an average price of $50.14 in 2030, with a high forecast of $60.82 and a low forecast of $39.45. This signifies an +73.18% surge from the last price of $28.95.
Month Average Low High Change from today's price
January, 2030 $43.15 $40.97 $43.21 +49.06%
February, 2030 $44.31 $42.76 $44.48 +53.07%
March, 2030 $46.29 $44.12 $46.93 +59.90%
April, 2030 $44.94 $44.16 $46.18 +55.24%
May, 2030 $46.00 $43.92 $46.20 +58.88%
June, 2030 $45.55 $45.29 $48.43 +57.33%
July, 2030 $44.60 $39.45 $47.27 +54.04%
August, 2030 $46.24 $42.95 $46.60 +59.72%
September, 2030 $52.31 $47.34 $52.77 +80.69%
October, 2030 $55.52 $51.75 $55.97 +91.77%
November, 2030 $58.96 $55.76 $59.81 +103.67%
December, 2030 $60.74 $58.09 $60.82 +109.82%
$90.18
price down icon 1.60%
$36.67
price up icon 0.71%
$103.35
price down icon 1.60%
biotechnology ONC
$314.85
price down icon 0.63%
$166.95
price up icon 1.00%
Cap:     |  Volume (24h):